✨ Medicine Consent Notices
NEW ZEALAND GAZETTE, No. 24 — 12 MARCH 2015
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Active Ingredients:
Augmentin
Amoxicillin sodium 530.1mg equivalent to Amoxicillin 500mg
Potassium clavulanate 119.13mg equivalent to Clavulanic acid 100mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
SmithKline Beecham Pharmaceuticals Limited, West Sussex, United Kingdom
Product:
Active Ingredients:
Augmentin
Amoxicillin sodium 1060.2mg equivalent to Amoxicillin 1000mg
Potassium clavulanate 238.25mg equivalent to Clavulanic acid 200mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
SmithKline Beecham Pharmaceuticals Limited, West Sussex, United Kingdom
Dated this 5th day of March 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go1394
Suspension of Consent to the Distribution of Medicines
Pursuant to section 35(1)(c) of the Medicines Act 1981, the Minister of Health hereby suspends consent to the distribution in New Zealand of the following medicines for a period of one year from 12 March 2015:
Schedule
Product:
Active Ingredient:
Pioglitazone Hydrochloride
Pioglitazone hydrochloride 16.54mg equivalent to Pioglitazone 15mg
Dosage Form:
Tablet
New Zealand Sponsor:
Dr Reddy’s New Zealand Limited
Manufacturer:
Dr Reddy’s Laboratories Limited, Andhra Pradesh, India
Product:
Active Ingredient:
Pioglitazone Hydrochloride
Pioglitazone hydrochloride 33.07mg equivalent to Pioglitazone 30mg
Dosage Form:
Tablet
New Zealand Sponsor:
Dr Reddy’s New Zealand Limited
Manufacturer:
Dr Reddy’s Laboratories Limited, Andhra Pradesh, India
Product:
Active Ingredient:
Pioglitazone Hydrochloride
Pioglitazone hydrochloride 49.61mg equivalent to Pioglitazone 45mg
Dosage Form:
Tablet
New Zealand Sponsor:
Dr Reddy’s New Zealand Limited
Manufacturer:
Dr Reddy’s Laboratories Limited, Andhra Pradesh, India
Product:
Active Ingredient:
Pramipexole Hydrochloride
Pramipexole hydrochloride monohydrate 0.125mg equivalent to Pramipexole 0.088mg
Dosage Form:
Tablet
New Zealand Sponsor:
Dr Reddy’s New Zealand Limited
Manufacturer:
Dr Reddy’s Laboratories Limited, Andhra Pradesh, India
Product:
Active Ingredient:
Pramipexole Hydrochloride
Pramipexole hydrochloride monohydrate 0.25mg equivalent to Pramipexole 0.18mg
Dosage Form:
Tablet
New Zealand Sponsor:
Dr Reddy’s New Zealand Limited
Manufacturer:
Dr Reddy’s Laboratories Limited, Andhra Pradesh, India
64
Next Page →
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines (Augmentin)
🏥 Health & Social Welfare5 March 2015
Medicine, Consent, Distribution, Augmentin, Amoxicillin, Clavulanic acid
- SARAH READER, Acting Group Manager, Medsafe, Ministry of Health
🏥 Suspension of Consent to the Distribution of Medicines (Pioglitazone and Pramipexole)
🏥 Health & Social Welfare12 March 2015
Medicine, Suspension, Distribution, Pioglitazone, Pramipexole
NZ Gazette 2015, No 24